References
- Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, DʼJourno XB, et al. International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 2015; 262: 286-94. doi: 10.1097/ SLA.0000000000001098
- Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016; 66: 271-89. doi: 10.3322/caac.21349
- van Putten M, de Vos-Geelen J, Nieuwenhuijzen G, Siersema PD, Lemmens VEPP, Rosman C, et al. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer 2018; 94: 138-47. doi: 10.1016/j. ejca.2018.02.025
- Soma D, Kawamura YI, Yamashita S, Wake H, Nohara K, Yamada K, et al. Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy. Dis Esophagus 2019; 32. pii: doy092. doi: 10.1093/dote/doy092
- Markar SR, Low DE. Physiology, not chronology, dictates outcomes after esophagectomy for esophageal cancer: outcomes in patients 80 years and older. Ann Surg Oncol 2013; 20: 1020-6. doi: 10.1245/s10434-012-2703-x
- Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539-47. doi: 10.1200/JCO.2012.45.2722
- Gonzalez MC, Correia MITD, Heymsfield SB. A requiem for BMI in the clinical setting. Curr Opin Clin Nutr Metab Care 2017; 20: 314-21. doi: 10.1097/MCO.0000000000000395
- Di Sebastiano KM, Mourtzakis M. A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer. Appl Physiol Nutr Metab 2012; 37: 811-21. doi: 10.1139/h2012-079
- Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge M-P, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol Bethesda Md (1985) 2004; 97: 2333-8. doi: 10.1152/japplphysiol.00744.2004
- Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saracino V, Barone C, et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget 2017; 8: 79884-96. doi: 10.18632/on-cotarget.20168
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010; 39: 412-23. doi: 10.1093/ageing/afq034
- Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009; 90: 1579-85. doi: 10.3945/ajcn.2009.28047
- Miljkovic I, Kuipers AL, Cvejkus R, Bunker CH, Patrick AL, Gordon CL, et al. Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men. Obes Silver Spring Md 2016; 24: 476-82. doi: 10.1002/oby.21328
- Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000; 49: 467-72. doi: 10.1016/s0026-0495(00)80010-4
- Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 2011; 18: 3579-85. doi: 10.1245/s10434-011-1976-9
- Antoun S, Lanoy E, Iacovelli R, Albiges-Sauvin L, Loriot Y, Merad-Taoufik M, et al. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies. Cancer 2013; 119: 3377-84. doi: 10.1002/cncr.28218
- Aubrey J, Esfandiari N, Baracos VE, Buteau FA, Frenette J, Putman CT, et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol Oxf Engl 2014; 210: 489-97. doi: 10.1111/apha.12224
- Jordan T, Mastnak DM, Palamar N, Kozjek NR. Nutritional therapy for patients with esophageal cancer. Nutr Cancer 2018; 70: 23-9. doi: 10.1080/01635581.2017.1374417
- Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr Edinb Scotl 2017; 36: 1187-96. doi: 10.1016/j. clnu.2017.06.017
- Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg 2004; 240: 205-13. doi: 10.1097/01.sla.0000133083.54934.ae
- Seder CW, Raymond DP, Wright CD, Gaissert HA, Chang AC, Clinton S, et al. The Society of Thoracic Surgeons General Thoracic Surgery Database 2017 update on outcomes and quality. Ann Thorac Surg 2017; 103: 1378-83. doi: 10.1016/j.athoracsur.2017.02.073
- Popuri K, Cobzas D, Esfandiari N, Baracos V, Jägersand M. Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle. IEEE Trans Med Imaging 2016; 35: 512-20. doi: 10.1109/ TMI.2015.2479252
- Chung H, Cobzas D, Birdsell L, Lieffers J, Baracos V. Automated segmentation of muscle and adipose tissue on CT images for human body composition analysis. Med Imaging 2009; 7261: p. 72610K. doi: 10.1117/12.812412
- van der Werf A, Langius JAE, de van der Schueren MAE, Nurmohamed SA, van der Pant KAMI, Blauwhoff-Buskermolen S, et al. Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population. Eur J Clin Nutr 2018; 72: 288-96. doi: 10.1038/s41430-017-0034-5
- Deng H-Y, Hou L, Zha P, Huang K-L, Peng L. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: a comprehensive systematic review and meta-analysis. Eur J Surg Oncol 2019; 45: 728-35. doi: 10.1016/j.ejso.2018.09.026
- Levolger S, van Vugt JLA, de Bruin RWF, IJzermans JNM. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg 2015; 102: 1448-58. doi: 10.1002/bjs.9893
- Waduud MA, Wood B, Keleabetswe P, Manning J, Linton E, Drozd M, et al. Influence of psoas muscle area on mortality following elective abdominal aortic aneurysm repair. Br J Surg 2019; 106: 367-74. doi: 10.1002/bjs.11074
- Stretch C, Aubin J-M, Mickiewicz B, Leugner D, Al-Manasra T, Tobola E, et al. Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. PloS One 2018; 13: e0196235. doi: 10.1371/journal.pone.0196235
- Paireder M, Asari R, Kristo I, Rieder E, Tamandl D, Ba-Ssalamah A, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol 2017; 43: 478-84. doi: 10.1016/j.ejso.2016.11.015
- Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg 2017; 266: 822-30. doi: 10.1097/SLA.0000000000002398
- Järvinen T, Ilonen I, Kauppi J, Salo J, Räsänen J. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol 2018; 16: 27. doi: 10.1186/s12957-018-1327-4
- Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-95. doi: 10.1016/S1470-2045(10)70218-7
- Nishigori T, Okabe H, Tanaka E, Tsunoda S, Hisamori S, Sakai Y. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol 2016; 113: 678-84. doi: 10.1002/jso.24214
- Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629-35. doi: 10.1016/S1470-2045(08)70153-0
- Dijksterhuis WPM, Pruijt MJ, van der Woude SO, Klaassen R, Kurk SA, van Oijen MGH, et al. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J Cachexia Sarcopenia Muscle 2019; 10: 199-206. doi: 10.1002/jcsm.12371
- Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-Ssalamah A. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastrooesophageal junction cancer. Eur Radiol 2016; 26: 1359-67. doi: 10.1007/s00330-015-3963-1
- Gabiatti CTB, Martins MCL, Miyazaki DL, Silva LP, Lascala F, Macedo LT, et al. Myosteatosis in a systemic inflammation-dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer. Cancer Med 2019; 8: 6967-76. doi: 10.1002/cam4.2593
- Boshier PR, Heneghan R, Markar SR, Baracos VE, Low DE. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2018; 31. doi: 10.1093/ dote/doy047
- Deng H-Y, Zha P, Peng L, Hou L, Huang K-L, Li X-Y. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis. Dis Esophagus 2019;32. doi: 10.1093/dote/doy115
- Tsukioka T, Nishiyama N, Izumi N, Mizuguchi S, Komatsu H, Okada S, et al. Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer. Jpn J Clin Oncol 2017; 47: 363-8. doi: 10.1093/jjco/hyx009
- JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012; 107: 931-6. doi: 10.1038/bjc.2012.350
- Achim V, Bash J, Mowery A, Guimaraes AR, Li R, Schindler J, et al. Prognostic indication of sarcopenia for wound complication after total laryngectomy. JAMA Otolaryngol Head Neck Surg 2017; 143: 1159-65. doi: 10.1001/ jamaoto.2017.0547
- Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012; 8: 457-65. doi: 10.1038/nrendo.2012.49
- Guinan EM, Doyle SL, Bennett AE, O’Neill L, Gannon J, Elliott JA, et al. Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance. Support Care Cancer 2018; 26: 1569-76. doi: 10.1007/s00520-017-3993-0
- Reisinger KW, Bosmans JWAM, Uittenbogaart M, Alsoumali A, Poeze M, Sosef MN, et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann Surg Oncol 2015; 22: 4445-52. doi: 10.1245/s10434-015-4558-4
- Yip C, Goh V, Davies A, Gossage J, Mitchell-Hay R, Hynes O, et al. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol 2014; 24: 998-1005. doi: 10.1007/s00330-014-3110-4
- Awad S, Tan BH, Cui H, Bhalla A, Fearon KCH, Parsons SL, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr Edinb Scotl 2012; 31: 74-7. doi: 10.1016/j.clnu.2011.08.008